Journal article
Continuous reactive crystallization of beta-lactam antibiotics catalyzed by penicillin G acylase. Part I: Model development
Computers & chemical engineering, v 123, pp 331-343
06 Apr 2019
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
A model is developed for simulating continuous manufacturing of beta-lactam antibiotics by enzymatic reactive crystallization. An amoxicillin case study using the unified model of reaction and crystallization kinetics in different reactor designs is presented. Attainable regions are constructed for conversion of amoxicillin precursors and mean crystal size. Attainable regions for conversion show that, with a 2:1 molar ratio of precursors, 98% conversion of the limiting reactant is possible with reactive crystallization while only 72% conversion can be achieved without crystallization. A well-mixed reactive crystallizer is shown to have higher productivity than a plug-flow reactive crystallizer, which is uncommon for positive-order processes like enzyme reactions and crystallization. A Pareto optimal surface is drawn for conversion, productivity, and fractional yield to inform the design of an optimal process. Additional means of optimizing production of amoxicillin, including classified crystal fines removal, are discussed to further enhance crystal size and productivity. (C) 2019 Elsevier Ltd. All rights reserved.
Metrics
Details
- Title
- Continuous reactive crystallization of beta-lactam antibiotics catalyzed by penicillin G acylase. Part I: Model development
- Creators
- Matthew A. McDonald - Georgia Institute of TechnologyAndreas S. Bommarius - Georgia Institute of TechnologyRonald W. Rousseau - Georgia Institute of TechnologyMartha A. Grover - Georgia Institute of Technology
- Publication Details
- Computers & chemical engineering, v 123, pp 331-343
- Publisher
- Elsevier
- Number of pages
- 13
- Grant note
- Cecil J. "Pete" Silas Endowment U01FD006484 / FDA Center for Drug Evaluation and Research Georgia Institute of Technology's Specialty Separation Center 1540017 / NSF I/UCRC Center for Pharmaceutical Development (CPD)
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- Chemical and Biological Engineering
- Web of Science ID
- WOS:000460650900023
- Scopus ID
- 2-s2.0-85060354164
- Other Identifier
- 991021958008504721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Web of Science research areas
- Computer Science, Interdisciplinary Applications
- Engineering, Chemical